Maxim Group analyst Michael Diana maintains Usio (NASDAQ:USIO) with a Buy and lowers the price target from $8 to $5.
What’s Going On With DMK Pharmaceuticals Stock?
DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares are trading higher Thursday after the company announced that it has regained the full rights to commercialize Zimhi (naloxone) after the termination of an exclusive commercialization and
